Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
17,747,231
-
Share change
-
+4,288,576
-
Total reported value
-
$89,784,168
-
Price per share
-
$5.20
-
Number of holders
-
56
-
Value change
-
+$21,171,828
-
Number of buys
-
30
-
Number of sells
-
25
Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q2 2018
As of 30 Jun 2018,
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,747,231 shares.
The largest 10 holders included
BB BIOTECH AG, BVF INC/IL, Omega Fund Management, LLC, FMR LLC, INTERWEST VENTURE MANAGEMENT CO, Opaleye Management Inc., Prosight Management, LP, Aisling Capital LLC, MILLENNIUM MANAGEMENT LLC, and VANGUARD GROUP INC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.